His primary scientific interests are in Microbiology, Bacillus anthracis, Virology, Anthrax Vaccine Adsorbed and Anthrax vaccines. The Microbiology study combines topics in areas such as Adjuvant, Anthrax toxin, Antigen and Virulence. As part of the same scientific family, Arthur M. Friedlander usually focuses on Bacillus anthracis, concentrating on Antibiotics and intersecting with Anesthesia and Vaccination.
His biological study spans a wide range of topics, including Immunogen and Intensive care medicine. His Anthrax Vaccine Adsorbed research integrates issues from Necrosis and Immunology. His Anthrax vaccines research includes themes of Ames strain and Inhalational anthrax.
Arthur M. Friedlander focuses on Microbiology, Bacillus anthracis, Virology, Virulence and Antigen. His Microbiology research incorporates themes from Immunogen, Yersinia pestis, Mutant and Immunity. His work carried out in the field of Bacillus anthracis brings together such families of science as Toxin, Immunology and In vivo.
He combines subjects such as Attenuated vaccine, Bacterial capsule, Virulence factor and Conjugate vaccine with his study of Virology. Arthur M. Friedlander has researched Virulence in several fields, including Bacillaceae, Bacillus cereus, Bacteria, Ames strain and Burkholderia mallei. The various areas that Arthur M. Friedlander examines in his Antigen study include Antibody, Monoclonal antibody and Recombinant DNA, Fusion protein.
Bacillus anthracis, Microbiology, Virulence, Innate immune system and Phagocytosis are his primary areas of study. Arthur M. Friedlander focuses mostly in the field of Bacillus anthracis, narrowing it down to topics relating to Biochemistry and, in certain cases, Molecular biology. His studies deal with areas such as Anthrax vaccines, Bacterial capsule, Mutant and Antigen as well as Microbiology.
His Anthrax vaccines study combines topics in areas such as Polyglutamate and Rhesus macaque. His Virulence study deals with Burkholderia mallei intersecting with Giant cell and Type three secretion system. His Phagocytosis research is multidisciplinary, relying on both Pathogen and Immunity.
His scientific interests lie mostly in Bacillus anthracis, Microbiology, Biochemistry, Bacterial capsule and Cell wall. His Bacillus anthracis study integrates concerns from other disciplines, such as Epitope and Virulence factor. The concepts of his Microbiology study are interwoven with issues in Neisseria meningitidis, Immune system, Interleukin 8 and Virology.
His Bacterial capsule research is multidisciplinary, incorporating perspectives in Anthrax vaccines, Serotype, Antigen, Immunogen and Conjugate vaccine. His research in Cell wall intersects with topics in In vitro, Mutant, Cell division and Virulence. His research integrates issues of Plasmid, Galactose, Polysaccharide, Peptidoglycan and S-layer in his study of Secondary cell wall.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Anthrax as a Biological Weapon Medical and Public Health Management
Thomas V. Inglesby;Donald A. Henderson;John G. Bartlett;Michael S. Ascher.
JAMA (1999)
Tularemia as a Biological Weapon.Medical and Public Health Management
David T. Dennis;Thomas V. Inglesby;Donald A. Henderson;John G. Bartlett.
JAMA (2001)
Anthrax as a biological weapon, 2002: updated recommendations for management.
Thomas V. Inglesby;Tara O’Toole;Donald A. Henderson;John G. Bartlett.
JAMA (2002)
Plague as a biological weapon. Medical and public health management.
Thomas V. Inglesby;David T. Dennis;Donald A. Henderson;John G. Bartlett.
JAMA (2000)
Clinical Recognition and Management of Patients Exposed to Biological Warfare Agents
Franz Dr;Jahrling Pb;Friedlander Am;McClain Dj.
JAMA (1997)
The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria
Timothy D. Read;Timothy D. Read;Scott N. Peterson;Scott N. Peterson;Nicolas Tourasse;Les W. Baillie;Les W. Baillie.
Nature (2003)
Postexposure Prophylaxis against Experimental Inhalation Anthrax
Arthur M. Friedlander;Susan L. Welkos;Margaret L. M. Pitt;John W. Ezzell.
The Journal of Infectious Diseases (1993)
In vitro correlate of immunity in a rabbit model of inhalational anthrax.
M.L.M Pitt;S.F Little;B.E Ivins;P Fellows.
Vaccine (2001)
Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine
Heath Dg;Anderson Gw;Mauro Jm;Welkos Sl.
Vaccine (1998)
Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis.
G. W. Anderson;S. E. C. Leary;E. D. Williamson;R. W. Titball.
Infection and Immunity (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
United States Army Medical Research Institute of Infectious Diseases
National Institutes of Health
University of Minnesota
The University of Texas Southwestern Medical Center
Johns Hopkins University School of Medicine
University of California, San Diego
Northern Arizona University
United States Army Medical Research Institute of Infectious Diseases
University of Chicago
Centers for Disease Control and Prevention
United States Army Medical Research Institute of Infectious Diseases
Publications: 51
Osaka University
Emory University
University of Tokyo
Chemnitz University of Technology
University of California, Irvine
Soochow University
Appalachian State University
Federal University of Toulouse Midi-Pyrénées
Friedrich Miescher Institute
Cornell University
University of East London
University of Münster
Brigham and Women's Hospital
University of California, Santa Barbara
Kyoto University
Fermilab